Reference - Detail
| RRC ID | 52026 |
|---|---|
| Author | Okuma K, Fukagawa K, Kohma T, Takahama Y, Hamaguchi Y, Ito M, Tanaka Y, Buonocore L, Rose JK, Hamaguchi I. |
| Title | A recombinant vesicular stomatitis virus encoding CCR5-tropic HIV-1 receptors targets HIV-1-infected cells and controls HIV-1 infection. |
| Journal | Microbes Infect |
| Abstract |
Anti-retroviral therapy is useful to treat human immunodeficiency virus type 1 (HIV-1)-infected individuals, but has some major problems, such as the generation of multidrug-resistant viruses. To develop a novel supplemental or alternative therapeutic for CCR5-tropic (R5) HIV-1 infection, we generated a recombinant vesicular stomatitis virus (rVSV) in which the gene encoding its envelope glycoprotein (G) was replaced with the genes encoding R5 HIV-1 receptors (human CD4 and CCR5), designated VSVΔG-CC5. Our present data demonstrate that this rVSV specifically infects cells that are transiently expressing R5 HIV-1 envelope glycoproteins, but does not infect those expressing CXCR4-tropic HIV-1 envelope glycoproteins. Notably, after a CD4+CCR5+ T cell line or primary cells initially infected with R5 HIV-1 were inoculated with G-complemented VSVΔG-CC5, the rVSV significantly reduced the number of HIV-1-infected cells, probably through direct targeting of the rVSV and VSV-mediated cytolysis and/or through syncytium formation- or cell-cell fusion-dependent killing, and markedly inhibited HIV-1 production. Furthermore, G-complemented VSVΔG-CC5 also efficiently inhibited HIV-1 infection in R5 HIV-1-infected humanized immunodeficient mice. Taken together, our findings indicate that a cytolytic rVSV that targets and eliminates R5 HIV-1-infected cells potentially has therapeutic value for controlling R5 HIV-1 infection. |
| Volume | 19(4-5) |
| Pages | 277-287 |
| Published | 2017-1-1 |
| DOI | 10.1016/j.micinf.2016.12.004 |
| PII | S1286-4579(16)30212-X |
| PMID | 28025070 |
| MeSH | Animals Antiviral Agents / pharmacology CD4 Antigens / genetics* CD4 Antigens / metabolism CD4-Positive T-Lymphocytes / metabolism CD4-Positive T-Lymphocytes / virology Cell Line Cricetinae HEK293 Cells HIV Infections / prevention & control* HIV Infections / virology HIV-1 / genetics Humans Mice Mice, Inbred BALB C Mice, Nude Oncolytic Virotherapy / methods* Receptors, CCR5 / genetics* Receptors, CCR5 / metabolism Receptors, CXCR4 / metabolism Vesiculovirus / genetics* Viral Envelope Proteins / genetics* Viral Load Virus Replication / genetics* |
| IF | 2.373 |
| Times Cited | 2 |
| Altmetric score |
オルトメトリクス指標項目
|
| The most frequently cited source | X(Twitter) |
| Total number of mentions | 19 |
| Altmetric score changes over past 6months | 0.0 |
| Resource | |
| Human and Animal Cells | BHK-21(RCB1423) |